Mini reviewPublished 29 Mar 2018
VXc-486 potent drug: A new drug approach in tuberculosis treatment.
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Tuberculosis (TB) is a communicable disease sometimes caused by the microorganism mycobacterium tuberculosis (MTB). Anti-tubercular agents inhibit the growth of Mycobacterium tuberculosis. Anti-tubercular agents mainly act by inhibit the growth of bacteria by cell wall synthesis inhibition. VXc-486 is a potent anti-tubercular drug belonging with aminobenzimidazole category. The novel amino-benzimidazole, VXc-486, which targets gyrase B, potently inhibits multiple drug-sensitive isolates and drug-resistant isolates of Mycobacterium tuberculosis. VXc-486 is crystalline and flakes in yellow color having solid state. It is crystalline solid at room temperature that show physical characteristic of the drug. VXc-486 is water insoluble potent anti-tubercular drug which is the Amino-benzimidazole family drug
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Translational Research
- SubjectInfectious Diseases
- SubjectPharmaceutical Sciences
- SubjectPulmonology & Respiratory
- BylineArticles whose byline prints “Sharma AK”
- BylineArticles whose byline prints “Sharma V”
- BylineArticles whose byline prints “Rathor R”
- BylineArticles whose byline prints “Khandelwal M”
- BylineArticles whose byline prints “Sharma M”
